Brief: Index Pharmaceuticals Gets Grant From Vinnova

Flerie AB

31/03/2020 07:06

March 31 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS RECEIVES GRANT FROM VINNOVA FOR
PRE-CLINICAL DEVELOPMENT OF DIMS COMPOUNDS IN INFLAMMATION
    * SEK 2.0 MILLION HAS BEEN GRANTED FROM SWEDEN'S INNOVATION
AGENCY
VINNOVA TO DEVELOP NEW, MORE EFFECTIVE AND SAFER TREATMENTS FOR
INFLAMMATORY DISEASES
    * PROJECT IS PLANNED TO START DURING SPRING 2020 AND
CONTINUE
UNTIL END OF 2021

Source text for Eikon:  ID:nWkr4W64Px 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))